subclinical hypothyroidism. Other specified hypothyroidism
Conditions
Interventions
Intervention 1: Intervention group: Levothyroxine tablet treatment intervention group with 50 micrograms once daily orally for 3 months (Iran Hormone Company 2). Intervention 2: Control group: In thi
Sponsors
Endocrinology and Metabolism Research Institute
Eligibility
Sex/Gender
All
Age
17 Years to 42 Years
Inclusion criteria
Inclusion criteria: age=17-42 5=10 NORMAL TotalT4
Exclusion criteria
Exclusion criteria: Smoking alcohol consumption Pregnancy and pregnancy intent Sodium levothyroxine consumption lipid lowering drugs Anti hypertensive drugs Taking vitamin supplements that affect the state of oxidative stress History of diabetes Mellitus - History of cardiovascular disease History of liver disease History of kidney disease
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Oxidant-Antioxidant balance. Timepoint: before intervention and 12 weeks after levothyroxin therapy. Method of measurement: serum sample.By the method of measuring prooxidant-antioxidant balance.Measurement of light spectrum by Eliza reader.;Hs-CRP. Timepoint: before intervention and 12 weeks after levothyroxin. Method of measurement: serum sample.Immunoturbidometry assay with commercial kit. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactNooshin Shirzad
Tehran University of Medical Sciences
Outcome results
None listed